Annual EBIT
-$151.08 M
-$15.47 M-11.41%
December 31, 2023
Summary
- As of February 7, 2025, KURA annual earnings before interest & taxes is -$151.08 million, with the most recent change of -$15.47 million (-11.41%) on December 31, 2023.
- During the last 3 years, KURA annual EBIT has fallen by -$62.03 million (-69.67%).
- KURA annual EBIT is now -570.37% below its all-time high of -$22.54 million, reached on December 31, 2015.
Performance
KURA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$53.99 M
-$3.56 M-7.06%
September 30, 2024
Summary
- As of February 7, 2025, KURA quarterly earnings before interest & taxes is -$53.99 million, with the most recent change of -$3.56 million (-7.06%) on September 30, 2024.
- Over the past year, KURA quarterly EBIT has dropped by -$11.60 million (-27.36%).
- KURA quarterly EBIT is now -1130.45% below its all-time high of -$4.39 million, reached on March 31, 2015.
Performance
KURA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$195.94 M
-$15.79 M-8.77%
September 30, 2024
Summary
- As of February 7, 2025, KURA TTM earnings before interest & taxes is -$195.94 million, with the most recent change of -$15.79 million (-8.77%) on September 30, 2024.
- Over the past year, KURA TTM EBIT has dropped by -$44.86 million (-29.69%).
- KURA TTM EBIT is now -4365.41% below its all-time high of -$4.39 million, reached on March 31, 2015.
Performance
KURA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
KURA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.4% | -27.4% | -29.7% |
| 3 y3 years | -69.7% | -27.4% | -29.7% |
| 5 y5 years | -154.0% | -27.4% | -29.7% |
KURA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -16.2% | at low | -66.4% | at low | -50.7% | at low |
| 5 y | 5-year | -141.5% | at low | -204.6% | at low | -213.2% | at low |
| alltime | all time | -570.4% | at low | -1130.5% | at low | -4365.4% | at low |
Kura Oncology EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$53.99 M(+7.1%) | -$195.94 M(+8.8%) |
| Jun 2024 | - | -$50.43 M(+2.7%) | -$180.15 M(+8.2%) |
| Mar 2024 | - | -$49.13 M(+15.9%) | -$166.50 M(+10.2%) |
| Dec 2023 | -$151.08 M(+11.4%) | -$42.39 M(+11.0%) | -$151.08 M(+6.7%) |
| Sep 2023 | - | -$38.20 M(+3.8%) | -$141.57 M(+1.9%) |
| Jun 2023 | - | -$36.79 M(+9.1%) | -$138.88 M(+1.5%) |
| Mar 2023 | - | -$33.70 M(+2.5%) | -$136.86 M(+0.9%) |
| Dec 2022 | -$135.61 M(+4.3%) | -$32.88 M(-7.4%) | -$135.61 M(+0.1%) |
| Sep 2022 | - | -$35.50 M(+2.1%) | -$135.47 M(+1.6%) |
| Jun 2022 | - | -$34.77 M(+7.1%) | -$133.33 M(+1.1%) |
| Mar 2022 | - | -$32.45 M(-0.9%) | -$131.92 M(+1.4%) |
| Dec 2021 | -$130.05 M(+46.0%) | -$32.74 M(-1.9%) | -$130.05 M(+5.5%) |
| Sep 2021 | - | -$33.37 M(+0.0%) | -$123.32 M(+8.6%) |
| Jun 2021 | - | -$33.36 M(+9.1%) | -$113.58 M(+12.9%) |
| Mar 2021 | - | -$30.59 M(+17.6%) | -$100.57 M(+12.9%) |
| Dec 2020 | -$89.05 M(+42.3%) | -$26.02 M(+10.1%) | -$89.05 M(+10.3%) |
| Sep 2020 | - | -$23.62 M(+16.1%) | -$80.75 M(+10.1%) |
| Jun 2020 | - | -$20.34 M(+6.7%) | -$73.38 M(+8.2%) |
| Mar 2020 | - | -$19.07 M(+7.6%) | -$67.83 M(+8.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$62.56 M(+5.2%) | -$17.72 M(+9.1%) | -$62.56 M(+3.0%) |
| Sep 2019 | - | -$16.25 M(+9.8%) | -$60.74 M(+2.5%) |
| Jun 2019 | - | -$14.79 M(+7.2%) | -$59.25 M(+0.5%) |
| Mar 2019 | - | -$13.79 M(-13.3%) | -$58.93 M(-0.9%) |
| Dec 2018 | -$59.48 M(+72.2%) | -$15.90 M(+7.8%) | -$59.48 M(+10.0%) |
| Sep 2018 | - | -$14.76 M(+2.0%) | -$54.07 M(+11.7%) |
| Jun 2018 | - | -$14.47 M(+0.9%) | -$48.42 M(+16.5%) |
| Mar 2018 | - | -$14.35 M(+36.7%) | -$41.56 M(+20.3%) |
| Dec 2017 | -$34.55 M(+28.0%) | -$10.50 M(+15.3%) | -$34.55 M(+10.7%) |
| Sep 2017 | - | -$9.11 M(+19.7%) | -$31.20 M(+8.2%) |
| Jun 2017 | - | -$7.61 M(+3.8%) | -$28.83 M(+4.1%) |
| Mar 2017 | - | -$7.33 M(+2.5%) | -$27.69 M(+2.6%) |
| Dec 2016 | -$26.98 M(+19.7%) | -$7.15 M(+6.3%) | -$26.98 M(+2.6%) |
| Sep 2016 | - | -$6.73 M(+4.0%) | -$26.30 M(+1.2%) |
| Jun 2016 | - | -$6.47 M(-2.3%) | -$26.00 M(+3.5%) |
| Mar 2016 | - | -$6.63 M(+2.3%) | -$25.11 M(+9.8%) |
| Dec 2015 | -$22.54 M | -$6.47 M(+0.7%) | -$22.88 M(+39.5%) |
| Sep 2015 | - | -$6.43 M(+15.1%) | -$16.40 M(+64.5%) |
| Jun 2015 | - | -$5.58 M(+27.3%) | -$9.97 M(+127.3%) |
| Mar 2015 | - | -$4.39 M | -$4.39 M |
FAQ
- What is Kura Oncology annual earnings before interest & taxes?
- What is the all time high annual EBIT for Kura Oncology?
- What is Kura Oncology annual EBIT year-on-year change?
- What is Kura Oncology quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Kura Oncology?
- What is Kura Oncology quarterly EBIT year-on-year change?
- What is Kura Oncology TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Kura Oncology?
- What is Kura Oncology TTM EBIT year-on-year change?
What is Kura Oncology annual earnings before interest & taxes?
The current annual EBIT of KURA is -$151.08 M
What is the all time high annual EBIT for Kura Oncology?
Kura Oncology all-time high annual earnings before interest & taxes is -$22.54 M
What is Kura Oncology annual EBIT year-on-year change?
Over the past year, KURA annual earnings before interest & taxes has changed by -$15.47 M (-11.41%)
What is Kura Oncology quarterly earnings before interest & taxes?
The current quarterly EBIT of KURA is -$53.99 M
What is the all time high quarterly EBIT for Kura Oncology?
Kura Oncology all-time high quarterly earnings before interest & taxes is -$4.39 M
What is Kura Oncology quarterly EBIT year-on-year change?
Over the past year, KURA quarterly earnings before interest & taxes has changed by -$11.60 M (-27.36%)
What is Kura Oncology TTM earnings before interest & taxes?
The current TTM EBIT of KURA is -$195.94 M
What is the all time high TTM EBIT for Kura Oncology?
Kura Oncology all-time high TTM earnings before interest & taxes is -$4.39 M
What is Kura Oncology TTM EBIT year-on-year change?
Over the past year, KURA TTM earnings before interest & taxes has changed by -$44.86 M (-29.69%)